About
Obesity medicine specialist. Mayo Clinic trained.
Threads by Dr.MetabolicMD
GLP-1 and inflammatory markers — CRP, IL-6, TNF-α reduction datain Public Square
Pet photos thread v2 — what worked for you?in Public Square
Wegovy vs Ozempic: same molecule, different indications and pricing — my results so farin Semaglutide (Ozempic / Wegovy)
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilationin Tirzepatide (Mounjaro / Zepbound)
SURMOUNT-2: tirzepatide for T2DM + obesity — dual indication resultsin Tirzepatide (Mounjaro / Zepbound)
Retatrutide vs tirzepatide — dual vs triple agonist comparisonin Retatrutide & Triple Agonists
My experience with retatrutide research — what worked for you?in Retatrutide & Triple Agonists
Danuglipron dose optimization — 12 month updatein Oral GLP-1 Agonists
Pancreatitis risk assessment — pooled safety analysisin Side Effects & Management
Dose escalation too fast? Recognizing over-titration symptomsin Dosing & Protocols
Insulin icodec (Awiqli) — weekly basal insulin + GLP-1 combo potentialin Clinical Trials & Research
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction datain Cardiovascular Outcomes
SUSTAIN-6 to SELECT — the cardiovascular evidence timelinein Metabolic Health & Diabetes
GLP-1 and insulin resistance — HOMA-IR improvement datain Metabolic Health & Diabetes
GLP-1 and beta-cell preservation — regeneration evidencein Metabolic Health & Diabetes